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ABSTRACT 
Introduction: Ebola virus disease is a severe, highly infectious, and often fatal illness. The 
pharmacists’ experience regarding Ebola in Sierra Leon is valuable for other countries, insofar they 
can learn from it and benefit from it globally. 
Objective: To describe the tasks carried out in Sierra Leone during the Ebola outbreak. 
Methods: This is a documentary review based on the regulations developed and the technical 
documents published by the Sierra Leone Ministry of Health. 
Conclusions: Health systems need collaborative work, especially in cases of epidemics or 
pandemics. The information presented shows what could be achieved in the Ebola epidemic for 
detecting emerging foci, as well as for guaranteeing communication among professionals, and for 
saving lives. This learning should be used, in the case of COVID-19, where interconnection among 
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professionals and health authorities is required, together with accurate and agile information targeted 
towards the population as well as coordinated progress to obtain the best treatments for patients. 
Keywords: Ebola; health professionals; global approach; pharmacist: pharmaceutical care; COVID-
19. 
RESUMEN 
Introducción: La enfermedad por el virus del Ébola es grave, muy infecciosa y, a menudo, 
mortal. La experiencia de los farmacéuticos en Sierra Leona en el enfrentamiento al ébola 
es valiosa para que otros países aprendan de estas prácticas y pueda haber un beneficio a 
nivel global.  
Objetivo: Describir las tareas desarrolladas en Sierra Leona durante el brote del Ébola. 
Métodos: Se trata de una revisión documental basada en la normativa desarrollada y los 
documentos técnicos publicados por el Ministerio de Salud de Sierra Leona. 
Conclusiones: Los sistemas de salud necesitan un trabajo colaborativo, especialmente en 
casos de epidemias o pandemias. La información presentada muestra lo que se podría lograr 
en la epidemia del Ébola, para detectar focos emergentes, comunicación entre profesionales 
y salvar vidas. Este aprendizaje debe ser utilizado en el caso de COVID-19 donde se requiere 
la interconexión entre profesionales y autoridades sanitarias, información veraz y ágil hacia 
la población y avances coordinados para obtener los mejores tratamientos para los pacientes. 





The nature of epidemics 
The current COVID-19 pandemic has generated different changes in the countries the health 
system, standardized guides in the countries,(1,2) reminding us that adverse reactions should 
be reported,(3,4) and the urgent need to implement pharmaceutical care,(5) as well as causing 
people and professionals to be affected,(6,7,8,) generating false information.(9) 
The epidemic of the Ebola virus showed the great speed with which an outbreak grows in a 
new environment. Ebola virus disease (EVD) was known among people in the tropical 
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regions of sub-Saharan Africa where the disease is endemic, unlike the inhabitants of 
Western Africa,(10,11). During the outbreak in 2015 there were fears of a pandemic,(12) there 
is no doubt that there are lessons to be learned from epidemics. In fact, mistakes were made 
in dealing with the EVD outbreak.(13,14). That is, the course of an epidemic, its outbreak and 
its decline follow the same pattern as any other natural process.(15) 
Ebola Virus Disease (EVD) is a severe, highly infectious, and often fatal illness. It is a viral 
hemorrhagic fever caused by a virus of the Ebolavirus genus, Filoviridae family (filovirus); 
the Zaire ebolavirus is the most dangerous of Ebola of this genus and has been caused most 
of the outbreaks so far, including the 2014 one and also, the mortality of previous outbreaks 
of EVD has been reported between 25% and 90%, with an average mortality rate of 50%.(16) 
Mortality rates vary depending on the area of the epidemic. Centers for Disease Control and 
Prevention (CDC),(17) established that diagnosing Ebola in a person infected for only a few 
days is difficult because of the preliminary symptoms, like fever, are nonspecific to infection 
by Ebola and often are detected in patients with more common infectious diseases, such as 
malaria and typhoid fever. Severely ill patients require intensive supportive care.  
Hydrocortisone may be used in patients that have impaired steroid synthesis by viral 
disruption of adrenal glands. Additionally, it is relevant to keep blood pressure and oxygen 
status and to treat infections if they occur. Mild pain and fever must be treated with 
paracetamol when necessary. For moderate to severe pain, opioids must be used. Aspirin, 
diclofenac, ibuprofen, and other non-steroidal anti-inflammatory drugs (NSAIDs) or any 
medicine that can have an anticoagulant effect are contraindicated, given the issue of 
bleeding associated with EVD. These patients usually are dehydrated and need oral 
rehydration with solutions or intravenous fluids that contain electrolytes. The fluid selection 
must consider the patient electrolyte balance.  
Prevention in population and health professionals 
Prevention of EVD is an essential first step in infection control.(18) In population, some 
prevention actions mut be done as reducing the risk of wildlife-to-human transmission, 
reducing the risk of human-to-human transmission, outbreak containment measures, 
reducing the risk of possible sexual transmission and reducing the risk of transmission from 
pregnancy related fluids and tissue. Healthcare workers who may be exposed to people with 
Ebola should follow several steps to ensure prevention of EVD: 
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− Train health personnel in the use of validated personal protective equipment (PPE). 
− Have Standardized Operational Procedures to ensure adequate measures of 
sterilization control and infections. 
− Identify patients with Ebola from other patients. Likewise, it is necessary to detect 
the relatives of the patient who may have been in direct contact. 
− To avoid that the personnel does not have due protection during the care patients’ 
activities (diagnosis and dispensing drugs) and despite the security to prevent the 
direct contact with the bodies of the people killed by Ebola.  
The previous information guide us to evaluate the strategies used in Sierra Leona in Ebola 
outbreak.  
The objective of this review is to describe the information developed in Sierra Leone in the 
case of the Ebola outbreak. 
Methods 
It was carried out a documentary review based in tasks developed by pharmacists in Sierra 
Leona during Ebola outbreak. 
This is a documentary review based on the regulations developed and the technical 
documents published by the Sierra Leone Ministry of Health, evaluating sources and 
strategies used. 
Awareness of events. EVD statistics 
Varkey et al. described uveitis caused by EVD between survivors. More specifically virus 
was detected in the aqueous humor 14 weeks after the onset of EVD and nine weeks after 
the clearance of viremia.(19)  
EVD is still alive in some countries. EVD outbreaks in Sierra Leone and Guinea were 
declared over in November and December 2015, respectively.(20) However, the Ebola virus 
is still infecting people. Despite the Ebola Virus Disease (EVD) being at epidemic levels in 
West Africa, health professionals continue to be on the front of serving each patient, for 
example, which arrives in hospital and pharmacies – the usual first step of access into the 
healthcare system. Therefore, it is imperative that lessons be learned from countries where 
health professionals have been at the forefront of treatment and prevention of EVD. Table 1 
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shows EVD cases in Guinea, Liberia, and Sierra Leone, obtained from the World Health 
Organization (WHO).(21) 
Table 1 - Confirmed, probable, and suspected EVD cases in Guinea, Liberia, and Sierra Leone 
until March 2nd, 2016(21) 
*Not reported due to the high proportion of probable and suspected cases that are reclassified.
‡Data not available. 
**Cases reported before 9 May 2015 are shaded blue. 
§Sierra Leone was declared free of Ebola virus transmission in the human population on
7 November 2015, and has now entered a 90-day period of heightened surveillance. 
Cases reported before 7 November 2015 are shaded blue. 
#Guinea was declared free of Ebola virus transmission in the human population on 29 December 
2015, and has now entered a 90-day period of heightened surveillance.
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Activities in Ebola Virus Disease by pharmacists 
Table 2 shows the EVD management activities, which can be conducted by pharmacists 
Table 2 - EVD management activities and the role of pharmacists 
EVD Management activities Goals 
1. Collaborating with establishment of
treatment and holding centres. 
- Share knowledge about how to create a new holding center. 
- Develop list of medicines and medical devices needed for EVD 
treatment. 
2. Deployment and training of pharmacy
staff and other non-health care workers. 
- Provide information on the epidemiology and transmission of 
Ebola virus disease (EVD) and the current Ebola epidemic. 
- Describe infection prevention and control principles as they pertain 
to working in Ebola Treatment Unit (ETU) in Africa. 
- Demonstrate the skills needed to work safely and efficiently in a 
well-designed ETU. 
- Describe how to evaluate personal and environmental safety within 
an ETU environment. 
- Describe the basic principles of clinical care and management of 
the patient with EVD. 
- Describe patient and community assessment and intervention 
strategies for Ebola treatment and control. 
3. Development of policy documents in
the case management and treatment of 
EVD victims and survivors of EVD, 
infection prevention and control 
procedures and preparation of 
disinfectants and antiseptics. 
- Develop requirements to register new drugs and to import drugs. 
- Develop documents and training for healthcare workers for the 
preparation of disinfectants and antiseptics. 
4. Emergency supply management of
medicines and other consumables. 
- Negotiate with providers to ensure medicines are in stock and 
correctly stored. 
- Describe infection prevention and control principles as they pertain 
to working in ETUs in Africa. 
The pharmacist plays a relevant role in more specific preventive activities related with 
people traveling without information about vaccinations needed for their destinations and 
recognition of travellers with symptoms suspicious of EVD. 
Some information strategies have been identified internationally. Regulatory agencies 
around the world have released information specifically on EVD. International 
Pharmaceutical Federation (FIP) has developed an advisory for EVD to assist and educate 
pharmacists globally on the prevention of EVD. Reports in different languages (English, 
Spanish, French, and German) are available on FIP´s Website.(16)  
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Efforts of the pharmaceutical industry in conjunction with the 
WHO(22,23,24) 
Response and lessons from Sierra Leona´s about EVD(25) 
Strategy 1: Strengthening of the health sector in emergencies. 
The national response included setting up holding and treatment centres, ensuring 
partnership with international and local organizations. Also pooling of resources, 
recruitment of all available health care professionals including recalling retired health 
personnel, training and deployment of healthcare professionals, mechanisms for disease 
alerts and information gathering, contact tracing, quarantine, and emergency burials. 
Additionally, recent vaccination, restriction of movement of the population from and within 
the affected zones and survivor re-integration and clinical case management care and follow 
up. 
Strategy 2: Mass public health education and awareness raising, population acceptability of 
the disease and behavior change. 
It was put together with the aim of involving religious leaders, politicians, local councils, 
traditional rulers, professional bodies, citizens, trade and business organizations, mass media 
(all forms from print to electronic and community announcements). Also, to ensure that 
accurate and correct information is disseminated to as wide and broad an audience as 
possible. 
Strategy 3: Pharmacy regulation and enforcement of proper pharmacy practice. 
It was aimed to assist pharmacists at the national medicines regulatory agency to build 
capacity rapidly through early training and development of rules and guidelines for 
evaluating and monitoring clinical trials in anticipation that new interventions for the 
diagnosis, prevention, and treatment of the Ebola Virus Disease would be brought into the 
country. Some pharmaceutical companies have been interested in registering experimental 
medicines against Ebola in Pharmacy Board of Sierra Leone (PBSL). Sierra Leone’s Ethics 
and Scientific Review Committee (SLERSC) is in charge of ethics approval of each clinical 
trial, ensuring a rigorous and ethical approach to the tests. Some of these products are 
Nanosilver, Zyphine compound, Immune formulation 200 (glutathione), NatuALA (5-
aminolevulinic acid), Synerzap (Doxycycline + garlic), Brincidofovir, EVD 003 
(Azithromycin, Irbesartan, Atorvastatin, Sunitinib).(25)  
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Technology use in EVD response 
Currently, technology is used for mapping and geolocation of Ebola outbreaks and to collect 
and share data in near real-time.(26) Other types of technological innovations - including gears 
for point-of-care diagnostics, patient-case management, administrative management, 
community displacement, paying and financial backing, and big data for analytics solutions 
from Ebola patients and affected human groups, ought to be used in the response.  
The World Health Organization (WHO) and other agencies are adapting existing eHealth 
tools to Ebola and building capacity to use them. Moreover, some technology firms are 
deploying short-term communication infrastructure solutions to boost broadband 
connectivity. Some of the available technologies to be used in EVD outbreak are shown in 
Table 3. For example, DHIS2 have been successfully used in some countries as Sir Lanka,(27) 
Kenya,(28) Peru,(29and Liberia.(30) 
Table 3 - Technology use in EVD response 
Technology 
proposal 





Explore and understand your data through great visualization features. Get the complete 
overview through the pivot table feature, spot trends in data with charting and visualize 
geographical data aspects using the Geographic Information System (GIS) functionality 
RapidPro https://community.rapidpro.io 
It is a free and open source framework designed to send and receive data using basic 
mobile phones, manage complex workflows, automate analysis, and present data in real-
time 
Frontline SMS http://www.frontlinesms.com 
Builds professional Short Message Service (SMS) management tools that help you reach 
more than 3 billion people with the phone already in their pocket 
Magpi http://home.magpi.com 
Mobile technology makes data collection, collaboration, and communication of data using 
mobile phone 
WhatsApp Ebola --- 
Easy and personal communication to spread information one to one or create groups for 
spread easier and faster using WhatsApp app. 
WHO DCP https://whodcp.org 
WHO Data Coordination Platform (DCP) for Secure management of electronic forms and 
data in real-time between health and development partners 
iHRIS http://www.ihris.org 
It is free and open source software for managing health workforce information. This 
information helps countries address health workforce shortages and solve other challenges 
across the health sector 
U-Report http://www.ureport.ug 
It is a free SMS social monitoring tool for community participation, designed to address 
issues that people care about 
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This kind of tools shown are so useful in different kind of health emergencies. In some cases, 
just a SMS can be needed to inform to population about behaviour expected to protect their 
self, especially because are free for users. Standard information can be developed and stored 
in this app to share in different situation: epidemic, pandemic, tsunami, etc. WhatsApp Ebola 
concretely have been an interesting way to share real-time information, using groups to 
spread information in seconds.  
During the September 2014 UN General Assembly meetings, UNICEF announced its 
investment in an open-source communication platform called RapidPro,(31) to enhance real-
time information flow in the field. In a NetHope Solutions Center webinar, the UNICEF 
Innovation team explained how they have adopted RapidPro,(31) and how other institutions 
can use it. RapidPro supply information live-saving information during natural disasters and 
epidemias/pandemias. Mercy Corps also shared a short presentation on how they are 
utilizing the solution in Liberia as part of their Ebola Community Action Platform (ECAP) 
program.(31) 
Health care systems around the world must encourage health professionals to engage in 
prevention activities with the population and the identification of EVD patients in healthcare 
system. This type of infection requires maximum efforts for control and avoidance of loss 
of lives, money, and reduces development in countries affected. 
It needs to use guidelines available mentioned in this article to improve performance in future 
prevention and treatment interventions to benefit patients with EVD. 
Conclusion 
Health systems need collaborative work, especially in cases of epidemics or pandemics. The 
information presented shows what could be achieved in the Ebola epidemic, to detect 
emerging foci, communication between professionals and save lives. This learning should 
be used in the case of COVID-19 where the interconnection between professionals and 
health authorities is required, accurate and agile information towards the population and 
coordinated progress to obtain the best treatments for patients. 
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